Professor Anita Grigoriadis is a leading expert in molecular and digital pathology, specialising in cancer research. She is the CEO of PharosAI and a Professor at King’s College London, where she directs innovative research into tumour microenvironments and AI-driven diagnostics. Her work focuses on using computational models and genomic data to improve cancer detection and treatment, particularly in breast cancer.

At King’s College London, she leads the Cancer Bioinformatics group, working closely with clinicians and scientists to develop precision medicine approaches. As an advocate for integrating AI into oncology, she plays a key role in PharosAI, a groundbreaking platform designed to harness NHS cancer data for AI-driven drug discovery and diagnosis. Her research has contributed to major advancements in understanding how cancer evolves and spreads, shaping the future of personalised medicine.